Search results
Author(s):
Mackram F Eleid
Added:
1 month ago
Explore advanced strategies for preventing and managing LVOT obstruction in transcatheter mitral valve replacement with Dr Mackram EleidThis presentation, part of Women As One's comprehensive Structural Interventions track, examines of a 90-year-old patient with severe mitral annular calcification, heart failure with preserved ejection fraction, and significant basal septal hypertrophy. Dr Eleid…
View more
Author(s):
Andrew Wang
Added:
1 month ago
AHA Scientific Sessions 2025 – MAPLE-HCM responder analysis shows aficamten monotherapy led to greater treatment effect when compared to metoprolol monotherapy.Dr Andrew Wang (Duke University Medical Center, Durham, NC, US) presents a responder analysis from the MAPLE-HCM trial (NCT05767346), examining clinical responses to aficamten monotherapy versus metoprolol in patients with obstructive…
View more
Author(s):
Milind Y Desai
Added:
3 months ago
ESC Congress 2025 - ODYSSEY-HCM finds no improvements in patients with non-obstructive cardiomyopathy when treated with mavacamten.Dr Milind Desai (Cleveland Clinic, US) joins us to discuss findings from the ODYSSEY-HCM trial, evaluating the safety, tolerability, and efficacy of mavacamten in patients with symptomatic non-obstructive hypertrophic cardiomyopathy.The ODYSSEY-HCM study was a…
View more
Author(s):
Giacomo Buso
,
Claudia Agabiti-Rosei
,
Matteo Lemoli
,
et al
Added:
1 year ago
Adrian Baranchuk
Research Area(s) / Expertise:
Job title: Professor of Medicine
Author
Hakim Ben Amer
Job title: Interventional Cardiologist
Author
Francisco Lopez-Jimenez
Research Area(s) / Expertise:
Job title: Director of the Cardiometabolic Program
Author
Andrew R Spector
Author
Author(s):
Gheorghe-Andrei Dan
,
Antoni Martínez-Rubio
Added:
10 months ago
Author(s):
Gregory Lewis
Added:
1 month ago
HFSA 25 - Aficamten improves excercise capacity compared to metoprolol in patients with obstructive hypertrophic cardiomyopathy in a prespecified analysis of the MAPLE-HCM study.Dr Gregory Lewis joins us to discuss findings from a prespecified cardiopulmonary exercise testing analysis of the MAPLE-HCM trial, which reveals divergent effects between aficamten and metoprolol on exercise performance…
View more